Bartalena L, Martino E, Velluzzi F, Piga M, Petrini L, Loviselli A, Grasso L, Pinchera A
Istituto di Endocrinologia, University of Pisa, Italy.
J Clin Endocrinol Metab. 1991 Sep;73(3):604-8. doi: 10.1210/jcem-73-3-604.
TSH secretion, with particular regard to the nocturnal TSH surge, was evaluated in 115 subjects with non-toxic nodular goiter. All patients were clinically and biochemically euthyroid. After 18-36 months of follow-up (mean, 24 months), hyperthyroidism occurred in 21 (18%; group 1), while the remaining 94 remained euthyroid (82%; group II). The analysis of hormonal data at the time of first observation showed that the 2 groups had similar total and free T4 and T3 serum concentrations. Morning serum TSH values in group I were lower than those in group II patients (0.6 +/- 0.1 vs. 1.1 +/- 0.1 mU/L; P less than 0.001); this difference was even more striking for the nocturnal values (0.6 +/- 0.1 vs. 2.2 +/- 0.2 mU/L; P less than 0.0001); nocturnal values were significantly lower than morning values in group II, but not in group I. The mean peak TSH value after TRH was also significantly reduced in group I (5.5 +/- 0.4 vs. 9.2 +/- 0.7 mU/L; P less than 0.001). Morning TSH values in group II did not differ from those in controls (1.3 +/- 0.1 mU/L), whereas nocturnal and TRH stimulated peak TSH values were slightly but significantly lower. The nocturnal serum TSH values in control subjects were 62-390% higher than morning values. The nocturnal TSH surge was abolished in 18 of 21 (86%) group I patients and in 7 of 94 (8%) group II patients. TRH testing resulted in an absent or blunted TSH responses in 5 subjects in group I and 6 in group II. Analysis by the Galen and Gambino predictive model; comparing the abolition of the nocturnal TSH surge and the abnormal TRH test as predictors of the subsequent occurrence of hyperthyroidism, showed that the former had higher sensitivity (86% vs. 24%) and predictivity (72% vs. 45%). In conclusion, the results of the present study demonstrate that the evaluation of the nocturnal TSH surge may be useful in identifying patients with nontoxic nodular goiter in whom hyperthyroidism may eventually occur. Patients who lack the nocturnal serum TSH surge are more prone to develop thyroid hyperfunction; their thyroid status should, therefore, be more carefully and frequently monitored.
对115例非毒性结节性甲状腺肿患者的促甲状腺激素(TSH)分泌情况,尤其是夜间TSH峰值进行了评估。所有患者临床及生化检查均显示甲状腺功能正常。经过18 - 36个月的随访(平均24个月),21例(18%;第1组)出现甲状腺功能亢进,其余94例仍甲状腺功能正常(82%;第II组)。首次观察时的激素数据分析表明,两组患者的总T4、游离T4及T3血清浓度相似。第1组患者早晨血清TSH值低于第II组患者(0.6±0.1 vs. 1.1±0.1 mU/L;P<0.001);夜间值的差异更为显著(0.6±0.1 vs. 2.2±0.2 mU/L;P<0.0001);第II组夜间值显著低于早晨值,但第1组并非如此。第1组促甲状腺激素释放激素(TRH)刺激后的平均TSH峰值也显著降低(5.5±0.4 vs. 9.2±0.7 mU/L;P<0.001)。第II组早晨TSH值与对照组(1.3±0.1 mU/L)无差异,而夜间及TRH刺激后的TSH峰值略低但有显著差异。对照组夜间血清TSH值比早晨值高62% - 390%。21例第1组患者中有18例(86%)夜间TSH峰值消失,94例第II组患者中有7例(8%)消失。TRH试验显示,第1组5例患者和第II组6例患者TSH反应缺失或减弱。采用盖伦和甘比诺预测模型分析;比较夜间TSH峰值消失及异常TRH试验作为随后发生甲状腺功能亢进的预测指标,结果显示前者具有更高的敏感性(86% vs. 24%)和预测性(72% vs. 45%)。总之,本研究结果表明,评估夜间TSH峰值可能有助于识别最终可能发生甲状腺功能亢进的非毒性结节性甲状腺肿患者。缺乏夜间血清TSH峰值的患者更容易发生甲状腺功能亢进;因此,应更仔细且频繁地监测他们的甲状腺状态。